发明名称 Joint use of sulfonamide based compound with angiogenesis inhibitor
摘要 <p>The present invention relates to a pharmaceutical composition comprising a sulfonamide-including compound in combination with a VEGF receptor kinase inhibitor as an angiogenesis, inhibitor, wherein the sulfonamide-including compound is N-(3-cyano-4-methyl-1 H-indol-7-yl)-3-cyanobenzenesulfonaxnide (E7820), or a pharmacologically acceptable salt thereof or a solvate thereof.</p>
申请公布号 EP2364699(A1) 申请公布日期 2011.09.14
申请号 EP20110169343 申请日期 2005.09.13
申请人 EISAI R&D MANAGEMENT CO., LTD. 发明人 OWA, TAKASHI;OZAWA, YOICHI;SEMBA, TARO
分类号 A61K31/18;A61K31/381;A61K31/404;A61K31/4439;A61K31/47;A61K31/4709;A61K31/498;A61K31/635;A61K31/64;A61K39/395;A61K45/06;A61P9/00;A61P35/00 主分类号 A61K31/18
代理机构 代理人
主权项
地址